The uremic retention solute p-cresyl sulfate and markers of endothelial damage

Björn K I Meijers1, Soetkin Van Kerckhoven, Kristin Verbeke

  • 1Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium.

Insights

In hemodialysis patients, the uremic toxin p-cresyl sulfate is linked to endothelial microparticle shedding. This suggests p-cresyl sulfate contributes to endothelial dysfunction in chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Toxicology

Background:

  • Cardiovascular disease is a major concern for chronic kidney disease patients.
  • The uremic retention solute p-cresol is linked to cardiovascular disease in hemodialysis patients.
  • Mechanisms linking p-cresol to cardiovascular disease remain unclear.

Purpose of the Study:

  • To investigate the association between p-cresol and markers of endothelial dysfunction in hemodialysis patients.
  • To determine the direct effects of p-cresol and its derivative p-cresyl sulfate on endothelial cells in vitro.

Main Methods:

  • Prospective observational study of 100 hemodialysis patients.
  • In vitro experiments using human umbilical vein endothelial cells.
  • Measured serum p-cresol, p-cresyl sulfate, soluble P-selectin, and endothelial microparticles.

Main Results:

  • Free serum p-cresol correlated with circulating endothelial microparticles in patients.
  • p-Cresyl sulfate induced dose-dependent shedding of endothelial microparticles in vitro.
  • Rho kinase inhibition blocked p-cresyl sulfate-induced microparticle shedding.

Conclusions:

  • p-Cresyl sulfate promotes endothelial microparticle shedding, suggesting a role in endothelial dysfunction in hemodialysis patients.
  • The in vitro findings indicate p-cresyl sulfate alters endothelial function independently of overt damage.
  • Further mechanistic studies are needed to explore the in vivo relationship.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...